Topic: Biotech

Biological Dynamics CEO Raj Krishnan and CFO Kevin Han shared what informs their vision for developing liquid biopsies to detect cancer at the earliest stages to ensure the best outcome for patients.

In Alzheimer’s disease, an overactive immune system kills off neuronal cells, leading to dementia. Now, scientists at Massachusetts General Hospital have pinpointed a protein involved in immune signaling they believe plays a key role in the progression of the disease.

Nimbus Therapeutics has raised $105 million to put its allosteric TYK2 inhibitor through a clutch of phase […]

Tenaya Therapeutics is fresh off a meaty raise but is quickstepping into a $100 million […]

Researchers at Rutgers University have developed a microchip that can perform real-time measurements of stress […]

Researchers at MIT have developed an e-skin technology that contains artificial sweat ducts. The ducts […]

Medtronic (NYSE:MDT) today presented study results for its InPen smart insulin pen and its extended-wear […]

  Edwards Lifesciences (NYSE:EW) has announced that its Acumen hypotension prediction index (HPI) software has […]

Dive Brief: The U.S. Preventive Services Task Force has finalized its position on screening for […]

Researchers at the University of California San Diego have developed a sweat sensor that measures […]

Advances in the testing of flexible circuits can improve feature inspection. Timothy Weber, Buehler Flexible […]

Cystic fibrosis drugs are the mainstay of the Vertex Pharmaceuticals portfolio now, but the company […]

Oncocyte (NSDQ:OCX) announced today that it completed its acquisition of molecular diagnostics company Chronix Biomedical. Irvine, […]

Qosina this week launched its product line for the single-use bioprocess industry. The new product […]

Researchers at McGill University in Canada have developed bioinspired sutures that mimic the structure of […]

Scientists in Cambridge, Mass. and Chennai, India, are touting the growth of self-organizing brain tissue […]

What’s the best way to stimulate the brain? For Helius Medical Technologies, it’s through the […]

On Thursday, Amazon landed an FDA Emergency Use Authorization for its COVID-19 test kit with […]

Momentum in biotech IPOs continued this week as four more companies made their stock market […]

Researchers at the Indian Institute of Science and SigTuple Technologies, a company based in Bengaluru, […]

As Moderna ramps up its COVID-19 vaccine efforts and has made one of the speediest […]

23andMe is going public through a $3.5 billion deal spearheaded by Sir Richard Branson’s Virgin Group. […]

Researchers at the Washington University in St. Louis have developed a microneedle patch that can […]

Thermo Fisher Scientific is diving a bit deeper into point-of-care coronavirus testing with its latest […]

Advaite announced today that it received FDA emergency use authorization for its RapCov point-of-care COVID-19 antibody […]

ClearMind Biomedical has announced 510(K) US Food and Drug Administration (FDA) clearance for its Axonpen […]

Israeli researchers have recently detailed a new machine learning-based COVID-19 model that predicts a positive […]

Dive Brief: Hologic announced late Tuesday its acquisition of Biotheranostics for $230 million, marking the second […]

23andMe filed an SEC Form D last month to confirm the sale of approximately $82.5 […]

Hologic (NSDQ:HOLX) announced today that it completed the acquisition of Somatex Medical Technologies GmbH for $64 million. Marlborough, […]

Currently no FDA-approved therapy for this serious condition afflicting over 15 million in the U.S., […]

Pfizer (NYSE:PFE) and its partner BioNTech (NSDQ:BNTX) announced that they will submit a request today with […]

Genetic code has served as the basis of the human story for millennia. Now, a […]

“The actual moment I remember quite vividly, I remember the room I was in,” says […]

Dive Brief: Computer vision-focused healthcare company Gauss Surgical on Monday announced its clinical study results for […]

The public health crisis of Covid-19 continues to cast a long shadow on business operations […]

Researchers at the University of Pennsylvania are touting a new way to potentially rebuild complex […]

PHILADELPHIA, Oct. 16, 2020 /PRNewswire/ — Enterin, Inc., a privately held, CNS-focused pharmaceutical company based in Philadelphia and developing novel […]

Abbott (NYSE:ABT) is reportedly set to hire 2,000 new employees to increase manufacturing for its rapid […]